Singular Genomics Systems Ownership 2024 | Who Owns Singular Genomics Systems Now?


OverviewRevenueFinancialsChartTranscripts

Institutional Ownership

34.51%

Insider Ownership

13.90%

Retail Ownership

51.59%

Institutional Holders

43.00

Singular Genomics Systems Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JPMORGAN CHASE & CO----38,815-100.00%-Jun 30, 2024
BANK OF AMERICA CORP /DE/----10,672-100.00%-Jun 30, 2024
WELLS FARGO & COMPANY/MN----384-100.00%-Jun 30, 2024
NORTHERN TRUST CORP----80,363-100.00%-Jun 30, 2024
STATE STREET CORP----112,615-100.00%-Jun 30, 2024
VANGUARD GROUP INC----1,872,582-100.00%-Jun 30, 2024
BARCLAYS PLC----12,284-100.00%-Jun 30, 2024
FMR LLC----2,119,635-100.00%-Jun 30, 2024
HARBOUR INVESTMENTS, INC.----172-100.00%-Jun 30, 2024
GOLDMAN SACHS GROUP INC----21,572-100.00%-Jun 30, 2024
MORGAN STANLEY----8,712-100.00%-Jun 30, 2024
ROYAL BANK OF CANADA----2,000-100.00%-Jun 30, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)----4,984,871-100.00%-Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC----111,200-100.00%-Jun 30, 2024
ORBIMED ADVISORS LLC----540,697-100.00%-Jun 30, 2024
MARINO, STRAM & ASSOCIATES LLC----40,000-100.00%-Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC----121,500-100.00%-Jun 30, 2024
RHUMBLINE ADVISERS----1,662-100.00%-Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC----460,639-100.00%-Jun 30, 2024
PERCEPTIVE ADVISORS LLC----2,126,893-100.00%-Jun 30, 2024

Singular Genomics Systems's largest institutional shareholder is JPMORGAN CHASE & CO, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JPMORGAN CHASE & CO----38,815-100.00%-Jun 30, 2024
BANK OF AMERICA CORP /DE/----10,672-100.00%-Jun 30, 2024
WELLS FARGO & COMPANY/MN----384-100.00%-Jun 30, 2024
NORTHERN TRUST CORP----80,363-100.00%-Jun 30, 2024
STATE STREET CORP----112,615-100.00%-Jun 30, 2024
VANGUARD GROUP INC----1,872,582-100.00%-Jun 30, 2024
BARCLAYS PLC----12,284-100.00%-Jun 30, 2024
FMR LLC----2,119,635-100.00%-Jun 30, 2024
HARBOUR INVESTMENTS, INC.----172-100.00%-Jun 30, 2024
GOLDMAN SACHS GROUP INC----21,572-100.00%-Jun 30, 2024
MORGAN STANLEY----8,712-100.00%-Jun 30, 2024
ROYAL BANK OF CANADA----2,000-100.00%-Jun 30, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)----4,984,871-100.00%-Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC----111,200-100.00%-Jun 30, 2024
ORBIMED ADVISORS LLC----540,697-100.00%-Jun 30, 2024
MARINO, STRAM & ASSOCIATES LLC----40,000-100.00%-Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC----121,500-100.00%-Jun 30, 2024
RHUMBLINE ADVISERS----1,662-100.00%-Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC----460,639-100.00%-Jun 30, 2024
PERCEPTIVE ADVISORS LLC----2,126,893-100.00%-Jun 30, 2024

The largest Singular Genomics Systems shareholder by % of total assets is JPMORGAN CHASE & CO. The company owns 0.00 shares of Singular Genomics Systems (OMIC), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
HARBOUR INVESTMENTS, INC.----172-100.00%-Jun 30, 2024
WELLS FARGO & COMPANY/MN----384-100.00%-Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----682-100.00%-Jun 30, 2024
RHUMBLINE ADVISERS----1,662-100.00%-Jun 30, 2024
DYNAMIC WEALTH STRATEGIES, LLC----1,700-100.00%-Jun 30, 2024
ROYAL BANK OF CANADA----2,000-100.00%-Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)----5,955-100.00%-Jun 30, 2024
MORGAN STANLEY----8,712-100.00%-Jun 30, 2024
BANK OF AMERICA CORP /DE/----10,672-100.00%-Jun 30, 2024
BARCLAYS PLC----12,284-100.00%-Jun 30, 2024
PALUMBO WEALTH MANAGEMENT LLC----12,549-100.00%-Jun 30, 2024
ENGINEERS GATE MANAGER LP----15,041-100.00%-Jun 30, 2024
GOLDMAN SACHS GROUP INC----21,572-100.00%-Jun 30, 2024
XTX TOPCO LTD----24,573-100.00%-Jun 30, 2024
DLK INVESTMENT MANAGEMENT, LLC----25,000-100.00%-Jun 30, 2024
JPMORGAN CHASE & CO----38,815-100.00%-Jun 30, 2024
MARINO, STRAM & ASSOCIATES LLC----40,000-100.00%-Jun 30, 2024
WEIL COMPANY, INC.----68,202-100.00%-Jun 30, 2024
NORTHERN TRUST CORP----80,363-100.00%-Jun 30, 2024
SQUAREPOINT OPS LLC----101,851-100.00%-Jun 30, 2024

As of Jun 30 2024, Singular Genomics Systems's largest institutional buyer is HARBOUR INVESTMENTS, INC.. The company purchased -0.17K stocks of OMIC, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)----4,984,871-100.00%-Jun 30, 2024
ARCH VENTURE MANAGEMENT, LLC----3,798,926-100.00%-Jun 30, 2024
QVIDTVM MANAGEMENT LLC----2,506,695-100.00%-Jun 30, 2024
UBS GROUP AG----2,209,383-100.00%-Jun 30, 2024
PERCEPTIVE ADVISORS LLC----2,126,893-100.00%-Jun 30, 2024
FMR LLC----2,119,635-100.00%-Jun 30, 2024
VANGUARD GROUP INC----1,872,582-100.00%-Jun 30, 2024
CASDIN CAPITAL, LLC----1,323,885-100.00%-Jun 30, 2024
BLACKROCK INC.----738,711-100.00%-Jun 30, 2024
ORBIMED ADVISORS LLC----540,697-100.00%-Jun 30, 2024
HIGHTOWER ADVISORS, LLC----528,324-100.00%-Jun 30, 2024
VERITION FUND MANAGEMENT LLC----500,000-100.00%-Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC----460,639-100.00%-Jun 30, 2024
TIKVAH MANAGEMENT LLC----316,854-100.00%-Jun 30, 2024
TRIATOMIC MANAGEMENT LP----194,731-100.00%-Jun 30, 2024
MILLENNIUM MANAGEMENT LLC----176,000-100.00%-Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC----121,500-100.00%-Jun 30, 2024
STATE STREET CORP----112,615-100.00%-Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC----111,200-100.00%-Jun 30, 2024
SQUAREPOINT OPS LLC----101,851-100.00%-Jun 30, 2024

As of Jun 30 2024, Singular Genomics Systems's biggest institutional seller is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C). The company sold -4.98M shares of OMIC, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)----4,984,871-100.00%-Jun 30, 2024
ARCH VENTURE MANAGEMENT, LLC----3,798,926-100.00%-Jun 30, 2024
QVIDTVM MANAGEMENT LLC----2,506,695-100.00%-Jun 30, 2024
UBS GROUP AG----2,209,383-100.00%-Jun 30, 2024
PERCEPTIVE ADVISORS LLC----2,126,893-100.00%-Jun 30, 2024
FMR LLC----2,119,635-100.00%-Jun 30, 2024
VANGUARD GROUP INC----1,872,582-100.00%-Jun 30, 2024
CASDIN CAPITAL, LLC----1,323,885-100.00%-Jun 30, 2024
BLACKROCK INC.----738,711-100.00%-Jun 30, 2024
ORBIMED ADVISORS LLC----540,697-100.00%-Jun 30, 2024
HIGHTOWER ADVISORS, LLC----528,324-100.00%-Jun 30, 2024
VERITION FUND MANAGEMENT LLC----500,000-100.00%-Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC----460,639-100.00%-Jun 30, 2024
TIKVAH MANAGEMENT LLC----316,854-100.00%-Jun 30, 2024
TRIATOMIC MANAGEMENT LP----194,731-100.00%-Jun 30, 2024
MILLENNIUM MANAGEMENT LLC----176,000-100.00%-Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC----121,500-100.00%-Jun 30, 2024
STATE STREET CORP----112,615-100.00%-Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC----111,200-100.00%-Jun 30, 2024
SQUAREPOINT OPS LLC----101,851-100.00%-Jun 30, 2024
NORTHERN TRUST CORP----80,363-100.00%-Jun 30, 2024
WEIL COMPANY, INC.----68,202-100.00%-Jun 30, 2024
MARINO, STRAM & ASSOCIATES LLC----40,000-100.00%-Jun 30, 2024
JPMORGAN CHASE & CO----38,815-100.00%-Jun 30, 2024
DLK INVESTMENT MANAGEMENT, LLC----25,000-100.00%-Jun 30, 2024
XTX TOPCO LTD----24,573-100.00%-Jun 30, 2024
GOLDMAN SACHS GROUP INC----21,572-100.00%-Jun 30, 2024
ENGINEERS GATE MANAGER LP----15,041-100.00%-Jun 30, 2024
PALUMBO WEALTH MANAGEMENT LLC----12,549-100.00%-Jun 30, 2024
BARCLAYS PLC----12,284-100.00%-Jun 30, 2024
BANK OF AMERICA CORP /DE/----10,672-100.00%-Jun 30, 2024
MORGAN STANLEY----8,712-100.00%-Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)----5,955-100.00%-Jun 30, 2024
ROYAL BANK OF CANADA----2,000-100.00%-Jun 30, 2024
DYNAMIC WEALTH STRATEGIES, LLC----1,700-100.00%-Jun 30, 2024
RHUMBLINE ADVISERS----1,662-100.00%-Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----682-100.00%-Jun 30, 2024
WELLS FARGO & COMPANY/MN----384-100.00%-Jun 30, 2024
HARBOUR INVESTMENTS, INC.----172-100.00%-Jun 30, 2024

Singular Genomics Systems's largest sold out institutional shareholder by shares sold is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), sold -4.98M shares, valued at -, as of undefined.

Singular Genomics Systems Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Vericimetry Funds0.08%7,430--Mar 31, 2024
BlackRock Advantage SMID Cap Fund, Inc.0.07%13,189--Mar 28, 2024
VANGUARD VALLEY FORGE FUNDS0.05%26,684--Mar 31, 2024
BRIDGEWAY FUNDS INC0.05%107,600--Mar 28, 2024
FRANKLIN STRATEGIC SERIES0.02%181,900--Jan 31, 2024
NEXPOINT FUNDS I0.02%67,954--Dec 31, 2023
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%8,166--Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC0.01%83,527--Mar 31, 2024
BNY Mellon Strategic Funds, Inc.0.01%23,118--Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 10.01%1,521--Mar 31, 2024
PFS FUNDS0.01%66,696-70,000-51.21%Feb 29, 2024
VANGUARD INDEX FUNDS0.00%1,829,232-649,099-26.19%Mar 31, 2024
VICTORY PORTFOLIOS0.00%98,156--Mar 31, 2024
FEDERATED HERMES INSURANCE SERIES0.00%10,000--Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%422,426-1,823-0.43%Feb 29, 2024
TIAA-CREF LIFE FUNDS0.00%4,694--Mar 31, 2024
Calvert Variable Products, Inc.0.00%3,653--Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%20,937--Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%19,503--Mar 31, 2024
SCHWAB CAPITAL TRUST0.00%23,488--Feb 29, 2024
Federated Hermes Equity Funds0.00%10,000--Jan 31, 2024
NORTHERN FUNDS0.00%53,287--Mar 28, 2024
Advisors' Inner Circle Fund III0.00%40,455--Jan 31, 2024
JPMORGAN TRUST II0.00%373,300--Feb 29, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%1,705--Mar 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%15,100--Mar 31, 2024
HC CAPITAL TRUST0.00%7,468--Mar 31, 2024
RYDEX SERIES FUNDS0.00%514--Dec 31, 2023
FIDELITY SALEM STREET TRUST0.00%467,096--Mar 31, 2024
T. Rowe Price Index Trust, Inc.0.00%2,227--Feb 29, 2024
VANGUARD SCOTTSDALE FUNDS0.00%196,396--Feb 29, 2024
VALIC Co I0.00%20,778--Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%8,661--Mar 31, 2024
TIAA-CREF FUNDS0.00%192,831--Mar 31, 2024
RYDEX DYNAMIC FUNDS0.00%254--Dec 31, 2023
PENN SERIES FUNDS INC0.00%1,800--Mar 28, 2024
ProFunds0.00%716--Mar 31, 2024
JPMorgan Trust I0.00%50,406--Jan 31, 2024
Guggenheim Active Allocation Fund0.00%244--Feb 29, 2024
RYDEX VARIABLE TRUST0.00%34--Dec 31, 2023
PROSHARES TRUST0.00%6,674--Feb 29, 2024
Brighthouse Funds Trust II0.00%22,098--Mar 31, 2024
USAA MUTUAL FUNDS TRUST0.00%5,143--Jan 31, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%2,075--Feb 29, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%21,358--Mar 31, 2024
BLACKROCK FUNDS0.00%130,459--Feb 29, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%46,100--Mar 31, 2024
SUNAMERICA SERIES TRUST0.00%6,468--Mar 31, 2024
Brighthouse Funds Trust I0.00%127,400--Mar 31, 2024
SEI INSTITUTIONAL MANAGED TRUST0.00%45,680--Dec 31, 2023
Blackstone Alternative Investment Funds0.00%600-100-14.29%Mar 31, 2023
MASTER INVESTMENT PORTFOLIO0.00%863--Mar 31, 2024
EQ ADVISORS TRUST0.00%10,708--Mar 31, 2024
iSHARES TRUST0.00%125,500-3,304-2.57%Mar 31, 2024
Dimensional ETF Trust0.00%2,552--Jan 31, 2024
Invesco Exchange-Traded Fund Trust II0.00%1,321--Jan 31, 2024
Bridge Builder Trust0.00%19,941--Mar 31, 2024
MASSMUTUAL SELECT FUNDS0.00%3,661--Dec 31, 2023
ETF Series Solutions0.00%70--Jan 31, 2024
PACIFIC SELECT FUND0.00%11,212--Mar 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%264--Jan 31, 2024
BlackRock Variable Series Funds, Inc.0.00%4,854--Mar 31, 2024
PRINCIPAL FUNDS, INC.0.00%6,012--Feb 29, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%1,117--Mar 31, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%2,500--Feb 29, 2024

Singular Genomics Systems's largest mutual fund holder by % of total assets is "Vericimetry Funds", owning 7.43K shares, compromising 0.08% of its total assets.

Singular Genomics Systems Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 2443-8.51%
31 Dec, 2347-2.08%
30 Sep, 2348-22.58%
30 Jun, 2362-7.46%
31 Mar, 2367-16.25%
31 Dec, 228012.68%
30 Sep, 2271-5.33%
30 Jun, 22758.70%
31 Mar, 226911.29%
31 Dec, 216219.23%
30 Sep, 2152-
30 Jun, 2152-

As of 31 Mar 24, 43 institutions are holding Singular Genomics Systems's shares, representing a decrease of -8.51% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2425,384,404-3.12%
31 Dec, 2326,201,129-2.99%
30 Sep, 2327,007,538-17.78%
30 Jun, 2332,847,914-8.33%
31 Mar, 2335,832,078-3.66%
31 Dec, 2237,191,849-7.51%
30 Sep, 2240,213,4153.06%
30 Jun, 2239,020,985-4.88%
31 Mar, 2241,021,8615.31%
31 Dec, 2138,953,71639.19%
30 Sep, 2127,985,6731.53%
30 Jun, 2127,563,193-

Singular Genomics Systems (OMIC) has 25.38M shares outstanding as of 31 Mar 24, down -3.12% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2434.51%2.69%
31 Dec, 2335.80%2.58%
30 Sep, 2337.25%1.79%
30 Jun, 2345.67%1.84%
31 Mar, 2349.82%1.82%
31 Dec, 2252.27%1.64%
30 Sep, 2256.47%1.86%
30 Jun, 2255.13%1.65%
31 Mar, 2257.77%1.98%
31 Dec, 2153.98%3.59%
30 Sep, 2138.78%0.51%
30 Jun, 2187.15%-

As of 31 Mar 24, Singular Genomics Systems is held by 34.51% institutional shareholders, representing a 2.69% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 2410-16.67%
31 Dec, 2312-
30 Sep, 2312-60.00%
30 Jun, 233042.86%
31 Mar, 2321-48.78%
31 Dec, 224120.59%
30 Sep, 2234-10.53%
30 Jun, 2238-25.49%
31 Mar, 225115.91%
31 Dec, 214418.92%
30 Sep, 2137-28.85%
30 Jun, 2152-

10 institutional shareholders have increased their position in OMIC stock as of 31 Mar 24 compared to 12 in the previous quarter (a -16.67% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 2410-28.57%
31 Dec, 2314-30.00%
30 Sep, 2320-
30 Jun, 2320-9.09%
31 Mar, 23224.76%
31 Dec, 222110.53%
30 Sep, 2219-32.14%
30 Jun, 2228180.00%
31 Mar, 221025.00%
31 Dec, 21833.33%
30 Sep, 216-
30 Jun, 21--

10 institutional shareholders have reduced their position in OMIC stock as of 31 Mar 24 compared to 14 in the previous quarter (a -28.57% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 2443-8.51%25,384,404-3.12%34.51%2.69%10-16.67%10-28.57%
31 Dec, 2347-2.08%26,201,129-2.99%35.80%2.58%12-14-30.00%
30 Sep, 2348-22.58%27,007,538-17.78%37.25%1.79%12-60.00%20-
30 Jun, 2362-7.46%32,847,914-8.33%45.67%1.84%3042.86%20-9.09%
31 Mar, 2367-16.25%35,832,078-3.66%49.82%1.82%21-48.78%224.76%
31 Dec, 228012.68%37,191,849-7.51%52.27%1.64%4120.59%2110.53%
30 Sep, 2271-5.33%40,213,4153.06%56.47%1.86%34-10.53%19-32.14%
30 Jun, 22758.70%39,020,985-4.88%55.13%1.65%38-25.49%28180.00%
31 Mar, 226911.29%41,021,8615.31%57.77%1.98%5115.91%1025.00%
31 Dec, 216219.23%38,953,71639.19%53.98%3.59%4418.92%833.33%
30 Sep, 2152-27,985,6731.53%38.78%0.51%37-28.85%6-
30 Jun, 2152-27,563,193-87.15%-52---

Singular Genomics Systems Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 14, 2024Spaventa Andrewdirector, officer Chief Executive OfficerM-ExemptSell1,906--26,687
Aug 14, 2024Spaventa Andrewdirector, officer Chief Executive OfficerF-InKindSell681$7.12$4.85K1,550
Aug 14, 2024Spaventa Andrewdirector, officer Chief Executive OfficerG-GiftSell1,225--325
Aug 13, 2024Ghai Jyotsnaofficer Chief Operating OfficerM-ExemptSell250--3,500
Aug 13, 2024Meeter Dalenofficer Chief Financial OfficerM-ExemptSell500--7,000
Aug 13, 2024Glezer Eli N.officer Chief Scientific OfficerM-ExemptSell500--7,000
Jun 18, 2024Meeter Dalenofficer Chief Financial OfficerM-ExemptSell6,250--68,750
Jun 18, 2024Glezer Eli N.officer Chief Scientific OfficerM-ExemptSell7,500--82,500
Jun 18, 2024Spaventa Andrewdirector, officer Chief Executive OfficerM-ExemptSell14,584--160,416
Jun 18, 2024Spaventa Andrewdirector, officer Chief Executive OfficerG-GiftSell14,584--9,766

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 14, 2024Spaventa Andrewdirector, officer Chief Executive OfficerG-GiftBuy1,225--139,963
Aug 14, 2024Spaventa Andrewdirector, officer Chief Executive OfficerM-ExemptSell1,906--26,687
Aug 14, 2024Spaventa Andrewdirector, officer Chief Executive OfficerM-ExemptBuy1,906--2,231
Aug 14, 2024Spaventa Andrewdirector, officer Chief Executive OfficerF-InKindSell681$7.12$4.85K1,550
Aug 14, 2024Spaventa Andrewdirector, officer Chief Executive OfficerG-GiftSell1,225--325
Aug 13, 2024Ghai Jyotsnaofficer Chief Operating OfficerM-ExemptSell250--3,500
Aug 13, 2024Ghai Jyotsnaofficer Chief Operating OfficerM-ExemptBuy250--600
Aug 13, 2024Meeter Dalenofficer Chief Financial OfficerM-ExemptBuy500--7,984
Aug 13, 2024Meeter Dalenofficer Chief Financial OfficerM-ExemptSell500--7,000
Aug 13, 2024Glezer Eli N.officer Chief Scientific OfficerM-ExemptBuy500--154,083
Aug 13, 2024Glezer Eli N.officer Chief Scientific OfficerM-ExemptSell500--7,000
Jun 18, 2024Meeter Dalenofficer Chief Financial OfficerM-ExemptBuy6,250--224,523
Jun 18, 2024Meeter Dalenofficer Chief Financial OfficerM-ExemptSell6,250--68,750
Jun 18, 2024Glezer Eli N.officer Chief Scientific OfficerM-ExemptBuy7,500--4,607,500
Jun 18, 2024Glezer Eli N.officer Chief Scientific OfficerM-ExemptSell7,500--82,500
Jun 18, 2024Spaventa Andrewdirector, officer Chief Executive OfficerG-GiftBuy14,584--4,162,144
Jun 18, 2024Spaventa Andrewdirector, officer Chief Executive OfficerM-ExemptSell14,584--160,416
Jun 18, 2024Spaventa Andrewdirector, officer Chief Executive OfficerM-ExemptBuy14,584--24,350
Jun 18, 2024Spaventa Andrewdirector, officer Chief Executive OfficerG-GiftSell14,584--9,766
May 31, 2024Eisenberg Marciadirector-A-AwardBuy55,500$0.37$20.65K55,500

The last insider sell of Singular Genomics Systems's stock was made by Spaventa Andrew on Aug 14 2024, selling 1,906 shares at - per share (valued at -).

Singular Genomics Systems Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 20245683.33%
Q2 2024159166.67%
Q1 2024105200.00%
Q4 202388100.00%
Q3 20237887.50%
Q2 2023118137.50%
Q1 20236--
Q4 202211100.00%
Q3 202211100.00%
Q2 2022125240.00%
Q1 20227--
Q4 2021-1-
Q2 2021113333.33%
Q1 2021---

5 total buy trades, and 6 total sell trades (buy/sell ratio of 0.83%) were made by Singular Genomics Systems's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024---
Q2 2024---
Q1 2024---
Q4 20233--
Q3 2023-3-
Q2 20231--
Q1 2023---
Q4 20221--
Q3 2022---
Q2 20221--
Q1 2022---
Q4 2021---
Q2 20212--
Q1 2021---

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Singular Genomics Systems's stocks.

Singular Genomics Systems Peer Ownership


TickerCompany
KRMDKORU Medical Systems, Inc.
ATRIAtrion Corporation
POCIPrecision Optics Corporation, Inc.
ANGOAngioDynamics, Inc.
LMATLeMaitre Vascular, Inc.
NSTGNanoString Technologies, Inc.
ATRAptarGroup, Inc.
PDEXPro-Dex, Inc.
UTMDUtah Medical Products, Inc.
NYXHNyxoah S.A.

OMIC Ownership FAQ


Singular Genomics Systems is owned by institutional shareholders (34.51%), insiders (13.90%), and public (51.59%). The largest institutional shareholder of Singular Genomics Systems is JPMORGAN CHASE & CO (0% of total shares) and the top mutual fund owner is Vericimetry Funds (0.08% of total shares).

Singular Genomics Systems's major institutional shareholders are JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, and STATE STREET CORP. The top five shareholders own together 0% of the company's share outstanding.

As of Mar 2024, there are 43 institutional shareholders of Singular Genomics Systems.

JPMORGAN CHASE & CO owns 0 shares of Singular Genomics Systems, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2024).

As of Jun 2024, BANK OF AMERICA CORP /DE/ holds 0 shares of Singular Genomics Systems (OMIC), compromising 0% of the company, valued at $0.

WELLS FARGO & COMPANY/MN is the third largest holder of Singular Genomics Systems. The company owns 0 of the company's shares outstanding (worth $0).